Literature DB >> 11005626

Changes in Th1/Th2 cytokine balance in Graves' disease.

T Kocjan1, B Wraber, U Repnik, S Hojker.   

Abstract

Graves' disease (GD) is characterised by hyperthyroidism, caused by stimulatory thyrotropin receptor (TSHR) antibodies. Recent research shows that an important factor in the pathogenesis of autoimmune diseases is the change in the balance between Th1 cytokines, which promote cell mediated immunity, and Th2 cytokines, which promote humoral immunity. There are contradictory data about this balance shift in GD. Our objective was to determine the Th1/Th2 cytokine balance shift in patients with newly diagnosed GD, when compared to the same balance in healthy controls. We isolated mononuclear cells (MNC) from the peripheral blood of healthy donors and from patients with newly diagnosed GD before treatment. The MNC were activated with ionomycin in combination with phorbol 12-myristate 13-acetate (PMA). After 40-hour incubation, the concentrations of the cytokines produced (IFN-gamma, IL-4, IL-10, IL-12) in the culture supernatants were measured by ELISA (Endogen, USA). The MNC cultures from patients with GD produced significantly less IL-12 and significantly more IL-10 and IL-4 than MNC cultures from healthy controls. All calculated ratios of Th1 against Th2 cytokines in MNC cultures from patients with GD were significantly lower than in MNC cultures from healthy controls. Our results show a systemic shift of cytokine production in patients with GD toward the Th2 cytokine response, thus confirming the key role of TSHR antibodies and humoral immunity in the pathogenesis of GD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005626

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  13 in total

1.  The -112G>A polymorphism of the secretoglobin 3A2 (SCGB3A2) gene encoding uteroglobin-related protein 1 (UGRP1) increases risk for the development of Graves' disease in subsets of patients with elevated levels of immunoglobulin E.

Authors:  Dimitry A Chistiakov; Natalia V Voronova; Rust I Turakulov; Kirill V Savost'anov
Journal:  J Appl Genet       Date:  2010-12-18       Impact factor: 3.240

2.  MiR-346 regulates CD4⁺CXCR5⁺ T cells in the pathogenesis of Graves' disease.

Authors:  Juan Chen; Jie Tian; Xinyi Tang; Ke Rui; Jie Ma; Chaoming Mao; Yingzhao Liu; Liwei Lu; Huaxi Xu; Shengjun Wang
Journal:  Endocrine       Date:  2015-02-11       Impact factor: 3.633

3.  Changes of regulatory T cells in Graves' disease.

Authors:  Hongxiang Wang; Shi Zhao; Xiaoqiong Tang; Jingyuan Li; Ping Zou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease.

Authors:  Rong-Hsing Chen; Wen-Chi Chen; Chwen-Tzuei Chang; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

5.  Can Digit Ratio (2D:4D) Be Indicative of Predispositions to Autoimmune Thyroid Diseases in Women - Hashimoto Thyroiditis and Graves' Disease?

Authors:  Barbara Święchowicz; Anna Kasielska-Trojan; John T Manning; Bogusław Antoszewski
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-30       Impact factor: 6.055

6.  Methimazole upregulates T-cell-derived cytokines without improving the existing Th1/Th2 imbalance in Graves' disease.

Authors:  T Kocjan; B Wraber; A Kocijancic; S Hojker
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

7.  Association between vitamin-D receptor gene FokI polymorphism and Graves' disease among Taiwanese Chinese.

Authors:  Rong-Hsing Chen; Chwen-Tzuei Chang; Huey-Yi Chen; Wen-Chi Chen; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

8.  The effects of royal jelly on autoimmunity in Graves' disease.

Authors:  Cihangir Erem; Orhan Deger; Ercüment Ovali; Yasam Barlak
Journal:  Endocrine       Date:  2006-10       Impact factor: 3.925

9.  A refined study of FCRL genes from a genome-wide association study for Graves' disease.

Authors:  Shuang-Xia Zhao; Wei Liu; Ming Zhan; Zhi-Yi Song; Shao-Ying Yang; Li-Qiong Xue; Chun-Ming Pan; Zhao-Hui Gu; Bing-Li Liu; Hai-Ning Wang; Liming Liang; Jun Liang; Xiao-Mei Zhang; Guo-Yue Yuan; Chang-Gui Li; Ming-Dao Chen; Jia-Lun Chen; Guan-Qi Gao; Huai-Dong Song
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

10.  The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto's thyroiditis but not in Graves' disease.

Authors:  Qiu Qin; Ping Liu; Lin Liu; Rong Wang; Ni Yan; Jing Yang; Xuan Wang; Madhu Pandey; Jin-an Zhang
Journal:  Braz J Med Biol Res       Date:  2012-10-23       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.